Concomitant metastatic head-and-neck cancer and pancreatic cancer assessed by αvβ6-integrin PET/CT using 68Ga-Trivehexin: incidental detection of a brain metastasis

Abstract

68 Ga-Trivehexin is an investigative PET radiopharmaceutical targeting the "cancer integrin" αvβ6, a tumor cell biomarker which is highly expressed by various carcinomas [1].Feasibility of targeting αvβ6-integrin for cancer imaging has been demonstrated in preclinical and first clinical